Success rate, quality of life, and descriptive analysis after generalized endometrial ablation in an obese population

International Journal of Gynecology and Obstetrics

Volumn 113, Issue 2, 2011, Pages 120-123

  Fakih, Mona ^a   Cherfan, Victor ^a   Abdallah, Eman ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Endometrial ablation; Menorrhagia; NovaSure; Obesity

Indexed keywords

ADULT; AMENORRHEA; ARTICLE; BLEEDING; BODY MASS; CLINICAL ARTICLE; DAILY LIFE ACTIVITY; DESCRIPTIVE RESEARCH; ENDOMETRIUM ABLATION; FEMALE; FOLLOW UP; HUMAN; MENORRHAGIA; OBESITY; PAIN; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL LIFE; TREATMENT OUTCOME; WORK SCHEDULE;

EID: 79953781361     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2010.11.018     Document Type: Article

References (22)

1. Shapley M, Jordan K, Croft P. An epidemiological survey of symptoms of menstrual loss in the community. Br J Gen Pract 2004;54(502):359-63. (Pubitemid 38584861)
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence in obesity among US adults, 1999-2008. J Am Med Assoc 2010;303(3):235-41.
3. World Health Organization. Obesity and Overweight. www.who.int. http://www.who.int/dietphysicalactivity/media/en/gsfs-obesity.pdf. Published 2003.
4. Mansfield PK, Voda A, Allison G. Validating a pencil-and-paper measure of perimenopausal menstrual blood loss. Womens Health Issues 2004;14(6):242-7. (Pubitemid 39602751)
5. Gallinat A. An impedance-controlled system for endometrial ablation: Five-year follow-up of 107 patients. J Reprod Med 2007;52(6):467-72. (Pubitemid 46981865)
6. Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value Health 2007;10(3):183-94. (Pubitemid 46802276)
7. Weber AM, Munro MG. Endometrial ablation versus hysterectomy: STOP-DUB. Medscape Womens Health 1998;3(3):3.
8. Baskett TF, Clough H, Scott TA. NovaSure bipolar radiofrequency endometrial ablation: report of 200 cases. J Obstet Gynaecol Can 2005;27(5):473-6.
9. Kleijn JH, Engels R, Bourdrez P, Mol BWJ, Bongers MY. Five-year follow up of a randomized controlled trial comparing NovaSure and Thermachoice endometrial ablation. Br J Obstet Gynaecol 2008;115(2):193-8. (Pubitemid 350233594)
10. Gallinat A, Nugent W. NovaSure impedance-controlled system for endometrial ablation. J Am Assoc Gynecol Laparosc 2002;9(3):283-9.
11. Fulop T, Rakoczi I, Barna I. NovaSure impedance controlled endometrial ablation: long-term follow-up results. J Minim Invasive Gynecol 2007;14(1):85-90. (Pubitemid 46049119)
12. Abbott J, Hawe J, Garry R. Quality of life should be considered the primary outcome for measuring success of endometrial ablation. J Am Assoc Gynecol Laparosc 2003;10(4):491-5. (Pubitemid 38020602)
13. Cooper J, Gimpelson R, Laberge P, Galen D, Garza-Leal JG, Scott J, et al. A randomized, multicenter trial of safety and efficacy of the NovaSure system in the treatment of menorrhagia. J Am Assoc Gynecol Laparosc 2002;9(4):418-28. (Pubitemid 36417265)
14. Busund B, Erno LE, Gronmark A, Istre O. Endometrial ablation with NovaSure GEA, a pilot study. Acta Obstet Gynecol Scand 2003;82(1):65-8. (Pubitemid 36228410)
15. Bradley L. New endometrial ablation techniques for treatment of menorrhagia. Surg Technol Int 2004;12:161-70.
16. Bongers MY, Mol BW, Brolmann HA. Prognostic factors for the success of thermal balloon ablation in the treatment of menorrhagia. Obstet Gynecol 2002;99(6):1060-6. (Pubitemid 34621232)
17. Parkin DE. Prognostic factors for success of endometrial ablation and resection. Lancet 1998;351(9110):1147-8. (Pubitemid 28171814)
18. El-Nashar SA, Hopkins MR, Creedon DJ, St Sauver JL, Weaver AL, McGree ME, et al. Prediction of treatment outcomes after global endometrial ablation. Obstet Gynecol 2009;113(1):97-106.
19. A randomised trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. Aberdeen Endometrial Ablation Trials Group. Br J Obstet Gynaecol 1999;106(4):360-6.
20. Asch DA, Jedrziewski KM, Christakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997;50(10):1129-36.
21. Gill TM, Feinstein AR. A critical appraisal of the quality of quality of life measurements. JAMA 1994;272(8):619-26. (Pubitemid 24255222)
22. Habiba M, Julian S, Taub N, Clark M, Rashid A, Baker R, et al. Limited role of multiattribute utility scale and SF-36 in predicting management outcome of heavy menstrual bleeding. Eur J Obstet Gynecol Reprod Biol 2010;148(1):81-5.